1O' Dwyer DT, Smith AI, Matthew ML, et al . Identification of the 49-kDa autoantigen associated with lymphocytic hypophysitis as alpha-enolase [J]. Clin Endocrino Metab, 2002,87 (2): 752 - 757.
2Flanagan DE, Ibrahim AE, Ellison DW, et al. Inflammatory hypophysitisthe spectrum of disease [ J ]. Acta Neurochir (wieh), 2002, 144 ( 1 ): 47 -56.
3Nakamura Y, Okada H, Wada Y, et al. Lymphocytic hypophysitis:its expanding features[J] .J Endocrinol Invest ,200l ,24(4) :262 - 267.
4Krimholtz MJ, Thomas S, Bingham J, et al. Lymphocytic hypophysitis:spontaneous resolution on MRI with progression of endocrine defect [J].Int J Clin Pract,2001,55(5) :339- 340.
3Assimakopoulou M, Zolota V, Chondrogianni C, et al. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas. Neuroendocrinology, 2008, 88(2):127-134.
4Camaris C, Balleine R, Little D. Microadenomas of the human pituitary. Pathology, 1995, 27(1):8-11.
5Horvath E. Pituitary hyperplasia. Pathol Res Pract, 1958, 183(5) :623-625.
7Jarzembowski J, Lloyd R, McKeever P. Type IV collagen immunostaining is a simple, reliable diagnostic tool for distin- guishing between adenomatous and normal pituitary glands. Arch Pathol Lab Med, 2007, 131 (6) :931-935.
